1 Market Overview
1.1 Pirfenidone Introduction
1.2 Market Analysis by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Mild Idiopathic Pulmonary Fibrosis
1.3.2 Moderate Idiopathic Pulmonary Fibrosis
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genentech (Roche)
2.1.1 Business Overview
2.1.2 Pirfenidone Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genentech (Roche) Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Shionogi
2.2.1 Business Overview
2.2.2 Pirfenidone Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shionogi Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 GNI Group
2.3.1 Business Overview
2.3.2 Pirfenidone Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GNI Group Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Beijing Continent
2.4.1 Business Overview
2.4.2 Pirfenidone Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beijing Continent Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Cipla
2.5.1 Business Overview
2.5.2 Pirfenidone Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cipla Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Lupin Ltd
2.6.1 Business Overview
2.6.2 Pirfenidone Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Ltd Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 Zydus Cadila
2.7.1 Business Overview
2.7.2 Pirfenidone Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Zydus Cadila Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 Glenmark Pharmaceuticals
2.8.1 Business Overview
2.8.2 Pirfenidone Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Koye Pharmaceuticals
2.9.1 Business Overview
2.9.2 Pirfenidone Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Koye Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 MSN Laboratories
2.10.1 Business Overview
2.10.2 Pirfenidone Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 MSN Laboratories Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Pirfenidone Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.12 Incepta Pharmaceuticals
2.12.1 Business Overview
2.12.2 Pirfenidone Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.13 Unimed Unihealth
2.13.1 Business Overview
2.13.2 Pirfenidone Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Unimed Unihealth Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Pirfenidone Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Pirfenidone Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Pirfenidone Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pirfenidone Manufacturer Market Share in 2019
3.3.2 Top 6 Pirfenidone Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Pirfenidone Market Analysis by Regions
4.1 Global Pirfenidone Sales, Revenue and Market Share by Regions
4.1.1 Global Pirfenidone Sales and Market Share by Regions (2015-2019)
4.1.2 Global Pirfenidone Revenue and Market Share by Regions (2015-2019)
4.2 North America Pirfenidone Sales and Growth Rate (2015-2019)
4.3 Europe Pirfenidone Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Pirfenidone Sales and Growth Rate (2015-2019)
4.5 South America Pirfenidone Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Pirfenidone Sales and Growth Rate (2015-2019)
5 North America Pirfenidone by Country
5.1 North America Pirfenidone Sales, Revenue and Market Share by Country
5.1.1 North America Pirfenidone Sales and Market Share by Country (2015-2019)
5.1.2 North America Pirfenidone Revenue and Market Share by Country (2015-2019)
5.2 United States Pirfenidone Sales and Growth Rate (2015-2019)
5.3 Canada Pirfenidone Sales and Growth Rate (2015-2019)
5.4 Mexico Pirfenidone Sales and Growth Rate (2015-2019)
6 Europe Pirfenidone by Country
6.1 Europe Pirfenidone Sales, Revenue and Market Share by Country
6.1.1 Europe Pirfenidone Sales and Market Share by Country (2015-2019)
6.1.2 Europe Pirfenidone Revenue and Market Share by Country (2015-2019)
6.2 Germany Pirfenidone Sales and Growth Rate (2015-2019)
6.3 UK Pirfenidone Sales and Growth Rate (2015-2019)
6.4 France Pirfenidone Sales and Growth Rate (2015-2019)
6.5 Russia Pirfenidone Sales and Growth Rate (2015-2019)
6.6 Italy Pirfenidone Sales and Growth Rate (2015-2019)
7 Asia-Pacific Pirfenidone by Country
7.1 Asia-Pacific Pirfenidone Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pirfenidone Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Pirfenidone Revenue and Market Share by Country (2015-2019)
7.2 China Pirfenidone Sales and Growth Rate (2015-2019)
7.3 Japan Pirfenidone Sales and Growth Rate (2015-2019)
7.4 Korea Pirfenidone Sales and Growth Rate (2015-2019)
7.5 India Pirfenidone Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Pirfenidone Sales and Growth Rate (2015-2019)
8 South America Pirfenidone by Country
8.1 South America Pirfenidone Sales, Revenue and Market Share by Country
8.1.1 South America Pirfenidone Sales and Market Share by Country (2015-2019)
8.1.2 South America Pirfenidone Revenue and Market Share by Country (2015-2019)
8.2 Brazil Pirfenidone Sales and Growth Rate (2015-2019)
8.3 Argentina Pirfenidone Sales and Growth Rate (2015-2019)
8.4 Colombia Pirfenidone Sales and Growth Rate (2015-2019)
9 Middle East and Africa Pirfenidone by Countries
9.1 Middle East and Africa Pirfenidone Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pirfenidone Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Pirfenidone Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Pirfenidone Sales and Growth Rate (2015-2019)
9.3 Turkey Pirfenidone Sales and Growth Rate (2015-2019)
9.4 Egypt Pirfenidone Sales and Growth Rate (2015-2019)
9.5 Nigeria Pirfenidone Sales and Growth Rate (2015-2019)
9.6 South Africa Pirfenidone Sales and Growth Rate (2015-2019)
10 Global Pirfenidone Market Segment by Type
10.1 Global Pirfenidone Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Pirfenidone Sales and Market Share by Type (2015-2019)
10.1.2 Global Pirfenidone Revenue and Market Share by Type (2015-2019)
10.2 Tablet Sales Growth and Price
10.2.1 Global Tablet Sales Growth (2015-2019)
10.2.2 Global Tablet Price (2015-2019)
10.3 Capsule Sales Growth and Price
10.3.1 Global Capsule Sales Growth (2015-2019)
10.3.2 Global Capsule Price (2015-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2015-2019)
10.4.2 Global Other Price (2015-2019)
11 Global Pirfenidone Market Segment by Application
11.1 Global Pirfenidone Sales Market Share by Application (2015-2019)
11.2 Mild Idiopathic Pulmonary Fibrosis Sales Growth (2015-2019)
11.3 Moderate Idiopathic Pulmonary Fibrosis Sales Growth (2015-2019)
11.4 Other Sales Growth (2015-2019)
12 Pirfenidone Market Forecast (2020-2025)
12.1 Global Pirfenidone Sales, Revenue and Growth Rate (2020-2025)
12.2 Pirfenidone Market Forecast by Regions (2020-2025)
12.2.1 North America Pirfenidone Market Forecast (2020-2025)
12.2.2 Europe Pirfenidone Market Forecast (2020-2025)
12.2.3 Asia-Pacific Pirfenidone Market Forecast (2020-2025)
12.2.4 South America Pirfenidone Market Forecast (2020-2025)
12.2.5 Middle East and Africa Pirfenidone Market Forecast (2020-2025)
12.3 Pirfenidone Market Forecast by Type (2020-2025)
12.3.1 Global Pirfenidone Sales Forecast by Type (2020-2025)
12.3.2 Global Pirfenidone Market Share Forecast by Type (2020-2025)
12.4 Pirfenidone Market Forecast by Application (2020-2025)
12.4.1 Global Pirfenidone Sales Forecast by Application (2020-2025)
12.4.2 Global Pirfenidone Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
